Advisory Board

Lester Thurow
Ph.D., Chairman of Advisory Committee

Dr. Lester Thurow has been a professor of Management and Economics at MIT for 30 years; He was the Dean of the MIT Sloan School from 1987 until 1993. He served as a staff economist on President Lyndon Johnson’s Council on Economic Advisers. He is a fellow of the American Academy of Arts and Sciences and served as vice president of the American Economic Association in 1993.

Alexander Leaf
M.D., Vice Chairman of Advisory Committee

Dr. Alexander Leaf has been honored as the fellow of US National Academy of Sciences and the Jackson Professor of Clinical Medicine, Emeritus, Harvard University. He served as chairman of the Department of Preventive Medicine at Harvard for 10 years. He is the pioneer in the study of the omega-3 of fish oil and proposed the preventive effect for fatal cardiac infarction, and established research lab of fatty acid metabolism in MGH. He has four students who won Nobel Prize.

Samuel Tinsing Mok
Vice Chairman of Advisory Committee

Mr. Samuel Tinsing Mok is the Managing Member of Condor International Advisors, LLC, a Washington DC based management consulting firm. From January 2001 to May 2007, Mr. Mok served as the Chief Financial Officer of the U.S. Department of Labor for the President George W. Bush administration... He previously served as Chief Financial Officer and Comptroller of the U.S. Department of the Treasury, appointed by former Treasury Secretary James Baker.

Stan Finkelstein
M.D., Vice Chairman of Advisory Committee

Dr. Stan N. Finkelstein is a Senior Research Scientist at MIT and Co-Director of the Program on the Pharmaceutical Industry (POPI). Since 1975, he has worked actively in the field of medical technology assessment and transfer at MIT. He conducts research and teaches classes on the development and evaluation of medical practice and technology, as well as on health economics and policy, both at MIT and Harvard Medical School. He is an active consultant to U.S. and international pharmaceutical, biotechnology, and medical device firms, as well as to health services organizations and government agencies.

John Halamka

John Halamka, MD, Professor of Medicine at Harvard Medical School, Chief Information Officer of Beth Israel Deaconess Medical Center, Chief Information Officer of Harvard Medical School, Chairman of the New England Healthcare Exchange Network (NEHEN), ?co-Chair of the national HIT Standards Committee, and a practicing Emergency Physician. As Chief Information Officer at CareGroup, he is responsible for all clinical, financial, administrative and academic information technology serving 3,000 doctors, 12,000 employees and one million patients. As Chief Information Officer and Associate Dean for Educational Technology at Harvard Medical School, he oversees all educational, research and administrative computing for 18,000 faculty and 3,000 students. As Chairman of NEHEN he oversees the administrative data exchange in Massachusetts. As CEO of MA-Share he oversees the clinical data exchange efforts in Massachusetts. As Chair of HITSP he coordinates the process of electronic standards harmonization among all the stakeholders nationwide. He is an advisory editor of North American Journal of Medicine and Science and honored educator/speaker of ACMES.

Peter Libby

Dr. Libby is the Chief of Cardiovascular Medicine at the Brigham and Women’s Hospital in Boston, Massachusetts. He also serves as the Mallinckrodt Professor of Medicine at Harvard Medical School. His current major research focus is the role of inflammation in vascular diseases such as atherosclerosis. Concepts that have evolved from his scientific work have changed thinking about how this common disease begins, the mechanisms that link risk factors to altered biology of the arterial wall, and the pathophysiology of the thrombotic complications of atherosclerosis including myocardial infarction and ischemic stroke. ?Clinical application of these discoveries has led to tests that can predict cardiovascular events and identify individuals who can benefit from therapies not otherwise indicated. His areas of clinical expertise include general and preventive cardiology. ?He is perennially named as one of America’s Top Doctors in the Castle-Connelly rankings, and was one of 25 cardiologists listed as a Top Doctor in 2010 by Boston Magazine. An author and lecturer on cardiovascular medicine and atherosclerosis, Dr. Libby has published over 300 original research reports in journals including Circulation, Journal of Clinical Investigation, Proceedings of the National Academy of Sciences, New England Journal of Medicine, Science, and Nature. He is Editor-in-Chief of the Eighth edition of Braunwald’s Heart Disease. Dr. Libby has also contributed the chapter on the pathogenesis, treatment, and prevention of atherosclerosis to many editions of Harrison’s Principles of Internal Medicine. He has held numerous visiting professorships and has been selected to deliver over 70 major named or keynote lectures throughout the world. Dr. Libby has received numerous awards and recognitions for his research accomplishments. ?Dr. Libby received the Distinguished Scientist award (basic domain) from the American College of Cardiology in 2006. ?Recent major recognitions include the Fernandez-Cruz Prize in 2008 (Madrid), and the inaugural International Teacher Award from the Brazilian Society of Cardiology in 2009, the Lucian Award for Circulatory Diseases from McGill University and the International Okamoto Award for Basic Research on Vascular Diseases in 2010. ?He has been awarded the Gold Medal of the European Society of Cardiology and the Basic Science Prize from the American Heart Association in 2011.

Dr. Libby’s professional memberships include the Association of American Physicians, the American Society for Clinical Investigation, and elected honorary memberships in the British Atherosclerosis Society and the Japan Circulation Society. He has served as the President of the Association of University Cardiologists. He also served in many roles as a volunteer for the American Heart Association, including chairman of several research committees and member of the executive committees of the Councils on Arteriosclerosis, Circulation, and Basic Science. He has frequently served as a consultant to the National Heart, Lung, and Blood Institute (NHLBI), including a 5-year term on the Board of Scientific Councilors. He was the recipient of a MERIT Award from the NHLBI..Dr. Libby has a particular interest in public education regarding heart disease, and served as the initiator and principal medical advisor to the acclaimed public television documentary series, The Mysterious Human Heart, which received an Emmy award. ?Dr. Libby writes a cardiovascular blog, “Consults-Experts on the Front Lines of Medicine”, for the New York Times website ( He is also the co-founder of a non-profit organization The International Partnership for Critical Markers of Disease ( to promote the development, evaluation, and appropriate clinical utilization of biomarker. Dr. Libby earned his medical degree at the University of California, San Diego, and completed his training in internal medicine and cardiology at the Peter Bent Brigham Hospital (now Brigham and Women’s Hospital). He also holds an honorary MA degree from Harvard University, and an honorary doctorate from the University of Lille. He is the honored speaker and educator of ACMES hospital management course and advisor of the society.

Ursula Kaiser

Dr. Kaiser is Chief of the Division of Endocrinology, Diabetes and Hypertension at Brigham and Women’s Hospital and Associate Professor of Medicine at Harvard Medical School. Dr. Kaiser received her medical degree and completed her clinical residency in Internal Medicine and fellowship in Endocrinology at University of Toronto Medical School in Canada. ?She joined the Division of Genetics at Brigham and Women’s Hospital and Harvard Medical School in 1990 to pursue research in pituitary hormone regulation. ?She was appointed to the faculty at Harvard Medical School and Brigham and Women’s Hospital in 1993 and to her current position as Chief, Division of Endocrinology, Diabetes and Hypertension at Brigham and Women’s Hospital in 2007.?

Dr. Kaiser has an active research program focused on the genetic and molecular mechanisms underlying the neuroendocrine regulation of reproductive development and function. Dr. Kaiser’s research has received continuous NIH support for over fifteen years. ?She is the Principal Investigator of several NIH R01 grants as well as the Associate Director of the Harvard Reproductive Endocrine Sciences Center, an NIH U54 Specialized Cooperative Center in Reproduction and Infertility Research. ?She is also the Program Director of the NIH-funded Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) program to train junior faculty in women’s health research. ?Dr. Kaiser is also an active clinician, focusing on neuroendocrinology and reproductive endocrinology. ?Dr. Kaiser is a member of the American Society of Clinical Investigation, and is the recipient of the Ernst Oppenheimer Award of the Endocrine Society and the A. Clifford Barger Excellence in Mentoring Award at Harvard Medical School.She is an advisor and executive member of ACMES, she is also advisory editor of North American Journal of Medicine and Science.

George C. Tsokos

George C. Tsokos, MD is a Professor of Medicine at Harvard Medical School;Chief, Rheumatology Division, Beth Israel Deaconess Medical Center, Boston, MA. His research and His clinical interest is cellular and molecular pathogenesis of systemic lupus erythematosus (SLE). His laboratory has opened and led the field of molecular abnormalities on immune cells in patients with SLE. Dr.Tsokos serves as associate editor of NAJMS.